UnknownPHASE2, PHASE3NCT01247012
Minimization of IntraLipid Versus Omegaven
Studying Parenteral nutrition-associated cholestasis
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Children's & Women's Health Centre of British Columbia
- Principal Investigator
- Susan Albersheim, MD, PhDChildren's & Women's Health Centre of BC
- Intervention
- Omegaven(dietary_supplement)
- Enrollment
- 40 target
- Eligibility
- All sexes
- Timeline
- 2010 – 2012
Study locations (1)
- Children's & Women's Health Centre of BC, Vancouver, British Columbia, Canada
Collaborators
Child and Family Research Institute
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT01247012 on ClinicalTrials.govOther trials for Parenteral nutrition-associated cholestasis
Additional recruiting or active studies for the same condition.
- RECRUITINGNCT06274788Safety Study to Evaluate the Occurrence of EFAD in Pediatric Patients With PNAC Who Require More Than Eight Weeks of Omegaven TreatmentFresenius Kabi
- RECRUITINGPHASE4NCT06049680Safety Study of SMOFlipid to Evaluate the Risk of Developing EFAD and/or PNAC in Pediatric and Adult PatientsFresenius Kabi
See all trials for Parenteral nutrition-associated cholestasis →